Next Article in Journal
Molecular and Cellular Mechanisms of Propolis and Its Polyphenolic Compounds against Cancer
Next Article in Special Issue
Analysis of 1-Aroyl-3-[3-chloro-2-methylphenyl] Thiourea Hybrids as Potent Urease Inhibitors: Synthesis, Biochemical Evaluation and Computational Approach
Previous Article in Journal
MicroRNAs in Medicinal Plants
Previous Article in Special Issue
Theoretical Design of a Janus-Nanoparticle-Based Sandwich Assay for Nucleic Acids
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 23
Issue 18
10.3390/ijms231810478
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Cloning and Characterization of Fructose-1,6-Bisphosphate Aldolase from Euphausia superba

by
Jikun Xia
1,2,
Wanmeng Xin
3,
Fang Wang
2,
Wancui Xie
1,
Yi Liu
3,* and
Jiakun Xu
2,*
1
College of Marine Science and Biological Engineering, Qingdao University of Science and Technology, Qingdao 266042, China
2
Key Lab of Sustainable Development of Polar Fisheries, Ministry of Agriculture and Rural Affairs, Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Lab for Marine Drugs and Byproducts of Pilot National Lab for Marine Science and Technology, Qingdao 266071, China
3
State Key Laboratory of Biocatalysts and Enzyme Engineering, School of Life Sciences, Hubei University, Wuhan 430062, China
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2022, 23(18), 10478; https://doi.org/10.3390/ijms231810478
Submission received: 10 August 2022 / Revised: 2 September 2022 / Accepted: 2 September 2022 / Published: 9 September 2022
(This article belongs to the Special Issue 2nd Edition: Advances in Molecular Simulation)
Browse Figures
Review Reports Versions Notes

Abstract

:
Fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) is a highly conserved enzyme that is involved in glycolysis and gluconeogenesis. In this study, we cloned the fructose-1,6-bisphosphate aldolase gene from Euphausia superba (EsFBA). The full-length cDNA sequence of EsFBA is 1098 bp long and encodes a 365-amino-acid protein. The fructose-1,6-bisphosphate aldolase gene was expressed in Escherichia coli (E. coli). A highly purified protein was obtained using HisTrap HP affinity chromatography and size-exclusion chromatography. The predicted three-dimensional structure of EsFBA showed a 65.66% homology with human aldolase, whereas it had the highest homology (84.38%) with the FBA of Penaeus vannamei. Recombinant EsFBA had the highest activity at 45 °C and pH 7.0 in phosphate buffer. By examining the activity of metal ions and EDTA, we found that the effect of metal ions and EDTA on EsFBA’s enzyme activity was not significant, while the presence of borohydride severely reduced the enzymatic activity; thus, EsFBA was confirmed to be a class I aldolase. Furthermore, targeted mutations at positions 34, 147, 188, and 230 confirmed that they are key amino acid residues for EsFBA.

1. Introduction

Fructose-1,6-bisphosphate aldolase (FBA, EC4.1.2.13) is a key enzyme in energy metabolism and is ubiquitously found. Glycolysis is a universal and fundamental biochemical pathway in carbohydrate metabolism. Fructose-1,6-bisphosphate aldolase (FBA) catalyzes the first step of glycolysis, which involves the cleavage of the six-carbon sugar backbone (fructose-1,6-bisphosphate) to generate two three-carbon intermediates [1,2,3,4]. Based on its catalytic mechanism and evolutionary origin, FBA can be divided into two types: class I aldolases and class II aldolases [5]. Class I FBAs are usually found in higher eukaryotes (animals and plants), where they use active-site lysine residues to stabilize the reaction intermediates through the formation of the Schiff base [6]. Its enzymatic activity can be inhibited by borohydride (usually NaBH4). Eukaryotic FBAs are homotetramers in which the subunits adopt the folding of parallel (βα)8-(TIM)-barrel [7,8,9]. Class II aldolases, found primarily in microorganisms as homodimers, require divalent metal cations (typically Zn2+) as cofactors to stabilize the carbonate intermediates formed by the substrate within the active site [10]. Thus, the activity of class II is competitively inhibited by the metal ion chelator EDTA [11]. Class I and class II aldolases have the same overall fold and catalyze the same overall reaction, but they do not share any significant sequence homology or common catalytic residues. Both types of aldolases can catalyze the cleavage of fructose-1,6-bisphosphate (FBP) to dihydroxyacetone phosphate (DHAP) and glyceraldehyde-3-phosphate (G3P) (Figure 1), which could provide ATP and substrates for the anabolism of biological substances [12,13,14]. In addition, a third class of aldolases has been reported, which are designated as class IA and are present in archaea (e.g., Thermomycetes, Fireball). These have a similar mechanism of action as class I aldolases and have been reported to exist as homo-octamers, decamers, or even higher oligomers [15,16].
As the most well-known DHAP-dependent aldolase [17], FBA has been used to produce important sugar derivatives, such as iminosugars, cyclitols, and complex natural products. Li [18] used FBA and three other enzymes to generate rare ketose molecules from various aldehyde substrates through a one-pot four-enzyme synthesis. FBA was shown to play an important role in combating hypoxia in sea turtles, and FBA increased the glycolytic output and alleviated hypoxia by increasing the level of FBA during hypoxia [19]. The upregulation of FBA gene expression in the muscle of Penaeus prawn infected with the white spot syndrome virus (WSSV) indicated that the FBA gene plays a role in the WSSV resistance of Penaeus prawn and is a disease-resistant gene; moreover, the physical interaction between aldolase and RNA polymerase II was thought to play a role in the regulation of hypoxic metabolism [20].
Euphausia superba is a small marine planktonic crustacean that lives in Antarctic waters and is known as the largest renewable animal protein pool for humans because of its large resources and high protein quality [21]. E. superba are extremely abundant and found throughout the Southern Ocean around Antarctica, with an annual biological catch of 100 million tons; therefore, it plays a key role in the Antarctic food web and is an important resource for fisheries [22,23]. E. superba contains many bioactive components, such as proteins, fatty acids, vitamins, minerals, and enzymes, and has become a hot topic of research in recent years [24,25,26]. E. superba can live in extreme environments and possesses qualities such as frost resistance and oxidation resistance [27,28,29]. In particular, the FBA from E. superba has great potential in the field of catalysis [30]. Because E. superba itself is prone to autoproteolysis, and it is difficult to isolate and extract the enzyme [31,32], scientists have attempted to develop E. superba-derived enzymes through genetic technology; FBA has not been studied in E. superba. Most studies on FBA have focused on heterologous expression in prokaryotes, mainly for vaccine development and diagnosis [33,34,35], whereas little research has been completed on eukaryotic FBA. In the past few years, scientists have been trying to achieve heterologous expression of key enzymes from E. superba, but no progress has been made. Therefore, studying FBA is not only conducive to understanding the evolutionary position of E. superba in the biosphere, but also provides a theoretical basis for the further application of fructose-1,6-bisphosphate aldolase. To our knowledge, this is the first report on the heterologous expression of FBA from E. superba (EsFBA).

2. Results and Discussion

2.1. Cloning and Bioinformatics Analysis

FBA in the EsFBA gene was validated by subcloning using krill cDNA as a template. The full-length EsFBA cDNA was 1098 bp long, containing 365 AA, with a molecular weight (Mw) of 39,820.37 Da. The theoretical pI was 7.59. The 365 AA include 43 positively charged residues (Asp + Glu) and 44 negatively charged residues (Arg + Lys). The instability index was 24.83 (<40), indicating that the EsFBA protein was stable. The aliphatic index was 81.56, indicating that the protein is soluble in lipids. We used ProtScale to perform a hydrophobic analysis of the protein and learned that it possesses more hydrophilic residues than hydrophobic residues, thus presuming that EsFBA is a hydrophilic protein. There was no O-glycosylation site; however, an N-glycosylation site was present at 73-NVSG. SWISS-MODEL was used to predict the 3D structure of the EsFBA (Figure 2A). Human A-type FBA was used as a template (Figure 2B). EsFBA is 65.38% homologous to the template, and the predicted structure of the EsFBA 3D model consists of 10 main β-stranded nuclei surrounded by 13 α-helices. The tetrameric structure is shown in Figure 2C,D.
The sequences obtained from sequencing were compared using NCBI Blast, and partial sequences with high similarity to FBA of E. superba were obtained. The highest similarity was found in Penaeus vannamei, followed by Penaeus monodon, zebrafish, Pike tritomata, and Drosophila melanogaster. The amino acid sequences encoded by the EsFBA were compared with each species for a multiple-sequence homology using DNAMAN8.0 (Figure 3).
The phylogenetic tree was made using MEGA-X for the above sequences (Figure S1). The results showed that the closest relatives to Euphausia superba were Penaeus vannamei with an 84.38% amino acid sequence similarity. It was 65.66% similar to Homo sapiens aldolase A, 59.34% similar to Homo sapiens aldolase B, and 65.38% similar to Homo sapiens aldolase C. From the phylogenetic tree and amino acid sequence similarity, it is clear that EsFBA belongs to the FBA family of genes, and the evolutionary relationship of this gene is generally consistent with the evolutionary status of the traditional species.

2.2. Protein Expression and Purification

The codon-optimized target gene fragment was 1131 bp in length, and the molecular weight (Mw) of the protein was 41,105.70. The synthesis of the optimized gene resulted in an amplification product (Figure S2A). The recombinant plasmid pET28-sfGFP-EsFBA was constructed and expressed in E. coli BL21 (DE3), as described in the methods Section 3.4. After isopropyl β-D-1-thiogalactopyranoside (IPTG) induction, HisTrap HP purification, and SDS-PAGE, a single band with a relative molecular mass of 45 kDa (Figure 4) was obtained. Compared with the predicted protein molecular weight of 41 kDa, this slight increase in molecular weight is due to the expression tag.

2.3. Expression Optimization of Recombinant Vectors

According to the results of the response surface analysis, the highest enzymatic activity of the EsFBA was observed at an induction temperature of 16 °C, an induction time of 16 h, and a final concentration of 0.55 mM of IPTG. The significance test analysis of the regression equation showed that the model was extremely significant (p < 0.001), and the missing items were not significant (p = 0.159 > 0.05). The data showed that the regression equation was a satisfactory fit, and the experimental error of the model was not significant; therefore, the regression equation can be used as a basis for predicting and analyzing the EsFBA enzyme activity [36]. The multiple quadratic regression model obtained was EsFBA activity = 1454.57 + 67.28A + 50.52B + 5.59C + 21.38AB − 23.96AC − 54.58BC − 352.09A2 − 249.28B2 − 268.25C2 (A: induction temperature; B: induction time; C: IPTG concentration). The F-values of the three influencing factors showed that the magnitude of the effect of each factor on the EsFBA enzyme activity was in the order A > B > C. All plots of the response surface were open downwards, with convex surfaces, and all had extreme values (Figure S3). The interaction of AB had a greater effect on the response value, the steepness of the entire surface was more pronounced, and the shape of the contours was close to elliptical, indicating that the interaction of the two factors was more significant.

2.4. Activity Analysis

The fructose-1,6-bisphosphate aldolase detection kit was used to determine the enzyme activity of the EsFBA. The purification multiple (specific activity after purification/specific activity before purification) and the recovery rate (total activity after purification/total activity before purification) of the purified enzyme were obtained (Table 1), that is, the EsFBA protein was purified 20.4-fold by HisTrap HP affinity chromatography. The specific activity of the purified enzyme was 193.5 U/mg.
The enzymatic activity of the EsFBA in this study was 18.1-fold higher than that of Ascaris suum (10.7 U/mg) [37], 15-fold higher than that of Staphylococcus aureus (12.9 U/mg) [38], 1.5-fold higher than that of blue-green algae [39], and 8.5-fold higher than that of sea turtles (22.8 U/mg) [19]; the high activity of the EsFBA may be related to the extremely low temperatures and long periods of diving time of E. superba.

2.5. Biochemical Characterization

The EsFBA enzyme activity increased as the reaction temperature increased from 10 °C to 45 °C, reaching a maximum activity at 45 °C (Figure 5a). The catalytic activity decreased while the temperature was greater than 45 °C. FBA from E. superba has a higher retained activity at higher temperatures compared to FBA from rabbit muscle (RAMA); EsFBA retained 20% activity at 70 °C, while RAMA lost almost all of its activity.
The pH of the reaction buffer is an important factor affecting the activity of the enzyme. The catalytic activity of the enzyme increased with an increase in pH between pH 4.0 and 7.0 (Figure 5b), reaching a maximum at pH 7.0. As the pH increased further between 7.0 and 9.0, the catalytic activity of the enzyme decreased. The conformation of the enzyme might change under different pH conditions, which could alter the binding or dissociation of the substrate from the active site of the enzyme, thereby affecting the enzyme activity.
The enzyme was highly stable at 20 °C and maintained 93.3% of its original activity after 2 h of incubation (Figure 5c). The enzyme activity was 70.6%, 65.4%, 7.1%, 1%, and 0.2% after 2 h of incubation at 30 °C, 40 °C, 50 °C, 60 °C, and 70 °C, respectively. In the pH stability test (Figure 5d), the enzyme activity could be maintained at 95% of its original activity after 2 h of incubation at pH 7.0. As acidity and alkalinity increased, the enzyme activity gradually decreased. At pH values of 4 and 9, the enzyme activity remained less than 70% after 2 h of incubation, indicating that EsFBA is a neutral enzyme.
It was demonstrated that the effect of 5 mmol/L of metal ions on the EsFBA enzyme activity was not significant. The relative enzyme activity after the influence of monovalent ions, such as K+ and Na+, was 125% and 122% (Figure 6). Meanwhile the divalent ions Cu2+, Mn2+, Mg2+, Ca2+, and Zn2+ had minimal effects on the enzyme activity: 111%, 107%, 96%, 120%, and 108%, respectively. More importantly, a 97% retention of the enzyme activity occurred under the influence of 5 mM EDTA, while 5 mM NaBH4 almost completely inhibited the EsFBA activity by 13%. The above results indicate that the addition of metal ions and EDTA did not significantly increase the enzymatic activity; on the contrary, the presence of borohydride significantly inhibited its enzymatic activity. It is possible that EsFBA does not necessitate the presence of metal ions as co-substrates, but rather catalyzes the reaction through Schiff base, indicating that EsFBA is a class I aldolase.

2.6. Site-Directed Mutagenesis

The D34K mutant exhibited catalytic ability (191.9 U/mg) similar to that of the wild type (193.5 U/mg) (Table 2). K147D showed 48% (93.2 U/mg) relative enzyme activity, E188H showed 74% (143.7 U/mg) relative enzyme activity, and K230D showed roughly half the activity (101.7 U/mg) of the wild type.
The evaluation of hydrogen bonding by PyMol showed that Lys147 and Lys230 are hydrogen-bonded to the substrate (Figure 7), which may be one of the reasons for the much-reduced enzyme activity after mutation at both sites. Furthermore, we deduced the active site of the substrate at the oxygen atom of its five-membered ring from the chemical equation of the FBP decomposition and measured the distance between the nitrogen atom of the mutant amino acid and the oxygen atom of the substrate action site (Figure 8). All mutated amino acids showed some degree of distance increase compared with the wild type, with D34K increasing from 4.9 to 6.4 Å, K147D increasing from 2.6 to 4.9 Å, E188H increasing from 3.1 to 4.6 Å, and K230D increasing from 4.9 to 5.9 Å. We speculate that the increase in the amino acid distance from the active site of the substrate also has an effect on enzyme activity. More importantly, they are involved in FBA binding to the substrate and Schiff base formation, which is perhaps the main reason for the reduced enzyme activity affecting the mutants. These results were consistent with previous studies [40,41,42]. Thus, based on results from the hydrogen-bond interaction analysis and changes in enzyme activity, Lys147 and Lys230 are the key amino acids of EsFBA.

3. Materials and Methods

3.1. Materials and Instruments

E. superba samples were kindly provided by the Liao Yu Group, who captured the samples in Antarctic waters in October 2019 and cryopreserved them at −80 °C until use. All chemicals were purchased from Sinopharm Reagent Co., Ltd. (Shanghai, China), Shanghai Sangon Biology Co., Ltd. (Shanghai, China), Dalian Takara Co., Ltd. (Dalian, China), and British OXOID Co., Ltd. (Basingstoke, UK) and used without further purification. Mettler Toledo S20 pH meter (Mettler Toledo, Greifensee, Switzerland), HH-1 electric constant temperature water bath (Changzhou Guohua, Changzhou, China), CR21GII high-speed refrigerated centrifuge (Hitachi, Tokyo, Japan), AKTA Explorer FPLC System (GE, Milwaukee, WI, USA), gel electrophoresis system (Bio-Rad, Hercules, CA, USA), and ultrapure water purification system (Millipore, Bedford, MA, USA) were used during the study.

3.2. Cloning and Bioinformatics Analysis

RNA was isolated from whole animals using the RNeasy system with on-column DNase treatment (Qiagen, Beijing, China). Genomic DNA was removed from total RNA by treatment with RNA-Free DNase (Thermo, Waltham, MA, USA). Reverse transcription reactions were performed using the PrimeScript 1st Strand cDNA Synthesis Kit (TaKaRa, kyoto, Japan). Then, the cDNA was used as a template to amplify the EsFBA gene, which was obtained through transcriptome sequencing. The EsFBA gene sequence has been submitted to NCBI, and the number is GenBank OP087496. Two primers, EsFBAF1(5′-GCGTCGCTAGCCACGC-3′) and EsFBAR1(5′-TTCCTGAGCCTTCCATC-3′), were synthesized. A polymerase chain reaction (PCR) was performed in a 25.0 μL reaction volume, containing 2.5 μL of 10 × PCR buffer, 2.5 μL of MgCl2, 2.0 μL of dNTP mix, 0.5 μL of Taq DNA polymerase (Qiagen), 15.5 μL of ddH2O, and 0.5 μL of each primer (10 mM). The PCR product was purified, subcloned into the pEasy-T vector (Qiagen), and transformed into the competent E. coli DH5α. The positive clone was sequenced to verify the full-length EsFBA cDNA. Based on the amino acid sequence, the molecular weight, isoelectric point, and affinity were predicted using ExPASy; the glycosylation site was predicted using NetNGlyc online; the 3D structure of the protein was predicted using SWISS-MODEL; and the BLAST comparison was performed using NCBI. The amino acid sequences of translated EsFBA were compared with DNAMAN, homology analysis was performed, and a phylogenetic tree was constructed using MEGA. Molecular docking simulations of EsFBA and substrate FBP were performed using Autodock software.

3.3. Construction of Recombinant Plasmid

We constructed a C-terminal 6× His-tagged sfGFP-EsFBA fusion protein expression plasmid using E. coli pET-28a; sfGFP has high solubility, bright fluorescence, fast-folding ability, high resistance to denaturants, and can be used as a fusion tag to promote the folding of heterologous proteins in E. coli [43,44]. The DNA fragments encoding the EsFBA tag and HRV 3C recognition site were amplified from the plasmid EsFBA by PCR using the primers 3C-EsFBA-F and EsFBA-R (Table S1). The DNA fragments, including the HRV 3C recognition site and sfGFP, were amplified from the plasmid sfGFP by PCR using the primers sfGFP-F and sfGFP-3C-R. The DNA fragment encoding sfGFP-3C-EsFBA was amplified from the above EsFBA and sfGFP PCR products using primers EsFBA-R/sfGFP-F and cloned into pET28a-T vector employing Nco I and Xho I. The plasmid was named pET28a-sfGFP-EsFBA.

3.4. Protein Expression and Purification

The plasmid pET28a-sfGFP-EsFBA was transformed into BL21(DE3) competent cells and transfected on Luria Bertani (LB) broth plates containing 100 µg/mL kanamycin. Individual colonies of BL21(DE3) cells were then cultured overnight on plates in a 250 mL flask containing 50 mL LB broth (containing 100 µg/mL kanamycin) at 37 °C and 200 rpm. Precultured cells were inoculated in 1 L flasks containing 100 mL LB and 100 μg/mL kanamycin and were grown at 37 °C and 200 rpm. Protein expression was induced by the addition of IPTG at a final concentration of 0.2 mM for 18 h at 16 °C. Cells were incubated at 200 rpm and 16 °C for 18 h. Cells were collected via centrifugation at 7654× g for 15 min, and the cell pellet was collected in PBS (135 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, and 8 mM K2HPO4; pH 8.0).
The cultures were washed twice in PBS and resuspended in 25 mL of PBS buffer containing 1 mM PMSF and 10 mM imidazole. The solution was sonicated for 30 min and centrifuged at 14,000 rpm for 0.5 h at 4 °C. The supernatant was subjected to HisTrap HP affinity chromatography, and the target protein was separated from the supernatant. The final purification was performed on the AKTA fast liquid chromatography system (GE Healthcare) using a PBS loading buffer and PBS elution buffer containing 500 mM imidazole at a flow rate of 1.0 mL/min. The first peak appeared as a penetration peak, followed by a gradual gradient elution to collect the target protein. The obtained samples were ultra-filtered at 30 kD, 4000 rpm, and imidazole was removed by the successive addition of PBS. The samples were analyzed for purity using 10% SDS-PAGE.

3.5. Optimization of Induction Conditions

The induction conditions were optimized using a response surface analysis and a three-factor three-level experimental design was carried out using Design Expert 10.0. Three aspects of optimal conditions were explored, including induction–inducer concentration (0.1–1 mmol/L), induction duration (12–20 h), and induction temperature (12–20 °C). Induction conditions for the highest enzyme activity were selected.

3.6. Activity Assay

The protein concentration was determined using the BCA protein assay kit (Solarbio, Beijing, China), and OD562 was monitored to calculate protein concentration. The enzyme activity was detected by fructose-1,6-bisphosphate aldolase assay kit (Figure 9) (Solarbio). FBA catalyzes the formation of FBP to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. Under the action of propanose phosphate isomerase and α-glycerol phosphate dehydrogenase, NADH and dihydroxyacetone phosphate are catalyzed to generate NAD+ and glycerol 3-phosphate. Since NADH has absorbance at 340 nm, the change in absorbance value at 340 nm is the change of NADH into NAD+. Subsequently, the activity of FBA can be reflected. Consumption of 1 nmol of NADH per mg of protein per minute was defined as one unit of enzyme activity. Briefly, 900 μL reagent and 100 μL protein samples were added to a colorimeter; absorbance was detected within 5 min at 340 nm and 25 °C. Three parallel groups were set up for each experiment.

3.7. Biochemical Characterization

Purified EsFBA was incubated at different temperatures (10 °C, 20 °C, 30 °C, 40 °C, 45 °C, 50 °C, 60 °C, and 70 °C) for 5 min at pH 7, followed by an activity assay using FBP as a substrate to determine the optimal temperature. The enzyme solution was placed in buffer solutions at different pH values (4.0, 5.0, 6.0, 7.0, 8.0, and 9.0) to determine the optimal pH, with 50 mmol/L Na2HPO4 citric acid buffer (pH 5.0–8.0) and 50 mmol/L glycine–NaOH buffer (pH 9.0, 50 mM). Purified EsFBA was placed in a metal bath at each temperature. The change in enzyme activity was measured at each temperature over 120 min; the highest enzyme activity was taken as 100%. Purified EsFBA was placed in a metal bath at 25 °C, and the enzyme activity at each pH was measured over 120 min, with the highest enzyme activity at 100%, as a test of the pH stability of EsFBA.
The effect of metal ions (Ca2+, K+, Na+, Mn2+, Cu2+, Mg2+, and Zn2+), EDTA, and NaBH4 with the final concentration of 5 mM was determined at pH 7.0 and 25 °C. The above solution was mixed with purified EsFBA in the appropriate proportions and left to stand for 2 h at 25 °C. The residual activity of EsFBA was assayed at 25 °C and pH 7. EsFBA, without the addition of metal ions and chemical reagents, was used as a control, and its activity was considered 100%.

3.8. Site-Directed Mutagenesis

Numerous studies have shown that amino acid residues inside neutral sites are highly conserved throughout evolution; Glu187, a conserved amino acid located in the active site of fructose-1,6-bisphosphate aldolases [45], plays a variety of roles in the catalytic cycle of aldolases. The residue responsible for the nucleophilic attack of the ketone substrate during Schiff base formation is located inside the active site of Lys229 [41]; Asp33 is involved in the extraction of protons from the C4 hydroxyl group [46], and studies suggest that this residue plays a key role in the catalytic mechanism. Lys146 is absolutely conserved in class I aldolases and is associated with the catalytic role of protein modifications [47]. Mutation of the above amino acid residues could verify the key amino acid sites of EsFBA and also confirm EsFBA’s relationship with other class I FBAs. Thus, we prepared four single mutants (D34K, K147D, E188H, and K230D) and investigated the catalytic ability of the enzyme.

3.9. Molecular Modeling

The tertiary structure of EsFBA was built by I-TASSER, which uses a hierarchical approach to protein structure prediction. The predicted structure was constructed using FBA (PDB code: 1FBA) as a template. The best model was further assessed using the PROCHECK plot in order to analyze the quality and consistency of the generated model. The structures of the D34K, K147D, E188H, and K230D mutants were simulated based on the predicted crystal structure of FBA using Insight II 2000/Discover 3 with Extensible Systematic Force Field. We obtained a unique structure for each mutant starting from several initial conformations. These structures were employed as rigid receptors for substrate docking. The Autodock 4 program was used to perform the docking of FBP into the active site of FBA mutants. The amino acid residues Lys108, Lys230, Gly302, and Ala304 were set as flexible residues. The ligand FBP for docking was generated by Dundee PRODRG server. Docked conformations were analyzed and ranked automatically by Autodock 4 using a free-energy scoring function. These results were then visualized using PyMol. Then, we used the Q5 site-directed mutagenesis kit, which contains 12.5 µL of master mix, 1 µL 10 µM of forward primer, 1 µL 10 µM of reverse primer, 1 µL of template DNA, and 9 µL of nuclease-free water. After PCR and KLD reaction, we performed receptor-cell ligation and transformation to obtain the mutant strain.

4. Conclusions

In this study, the FBA gene from E. superba was cloned. The full-length cDNA sequence of EsFBA is 1098 bp, encoding a protein of 365 amino acids. By comparing multiple sequences and building a phylogenetic tree, we found that the EsFBA had the highest homology (84.38%) with the FBA of P. vannamei. We expressed the EsFBA in E. coli and obtained pure protein. The optimum temperature of the recombinant EsFBA was 45 °C, and the optimum pH was 7. While 5 mM of metal ions and EDTA had little effect on the EsFBA enzymatic activity, the borohydride inhibited it, demonstrating that EsFBA is a class I aldolase. Furthermore, point mutations allowed us to verify important sites of EsFBA activity, with mutants showing a reduced catalytic activity compared to the wild type. Compared with aldolase from rabbit muscle, EsFBA retained relatively high activity at a high temperature, and, compared with other species, the activity of the FBA from E. superba was more than ten times higher. Therefore, EsFBA could be used as a potential new enzyme for development and utilization. This study provides a theoretical basis for the use of E. superba.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/ijms231810478/s1.

Author Contributions

The study and experiments were conceived and designed by J.X. (Jiakun Xu), Y.L. and W.X. (Wancui Xie) and then performed by J.X. (Jikun Xia) and W.X. (Wanmeng Xin). Results were analyzed by J.X. (Jikun Xia) and F.W. The paper was written by J.X. (Jikun Xia). All authors contributed to reading and correcting the paper. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Central Public-interest Scientific Institution Basal Research Fund, CAFS(NO.2020TD67); Open Fund Project of Key Lab of Sustainable Development of Polar Fisheries, Ministry of Agriculture and Rural Affairs, PRC(2022OPF01).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Not applicable.

Acknowledgments

It is a pleasure to acknowledge Yingwu Lin at the University of South China, for helping to map mutant structures. We also acknowledge Fengxiao Ji at Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, for calculating the 3D structure of EsFBA.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Campanella, M.E.; Chu, H.; Low, P.S. Assembly and regulation of a glycolytic enzyme complex on the human erythrocyte membrane. Proc. Natl. Acad. Sci. USA 2005, 102, 2402–2407. [Google Scholar] [CrossRef] [PubMed]
  2. Mazurek, S.; Zwerschke, W.; Jansen-DüRR, P.; Eigenbrodt, E. Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: Role of pyruvate kinase type M2 and the glycolytic-enzyme complex. Biochem. J. 2001, 356, 247–256. [Google Scholar] [CrossRef] [PubMed]
  3. Brooks, S.P.J.; Storey, K.B. Reevaluation of the “glycolytic complex” in muscle: A multitechnique approach using trout white muscle. Arch. Biochem. Biophys. 1988, 267, 13–22. [Google Scholar] [CrossRef]
  4. Singh, P.; Salih, M.; Leddy, J.J.; Tuana, B.S. The Muscle-specific Calmodulin-dependent Protein Kinase Assembles with the Glycolytic Enzyme Complex at the Sarcoplasmic Reticulum and Modulates the Activity of Glyceraldehyde-3-phosphate Dehydrogenase in a Ca2+/Calmodulin-dependent Manner. J. Biol. Chem. 2004, 279, 35176–35182. [Google Scholar] [CrossRef] [PubMed]
  5. Rutter, W.J.; Hunsley, J.R.; Groves, W.E.; Calder, J.; Woodfin, B.M. Fructose diphosphate aldolase. Methods Enzymol. 1966, 9, 479–498. [Google Scholar]
  6. Ocampos, D.; Bacila, M. Purification and properties of fructose-1,6-diphosphate aldolase from beef heart muscle. An. Acad. Bras. Cienc. 1975, 47, 551–556. [Google Scholar]
  7. Gamblin, S.J.; Cooper, B.; Millar, J.R.; Davies, G.J.; Littlechild, J.A.; Watson, H.C. The crystal structure of human muscle aldolase at 3.0 resolution. FEBS Lett. 1990, 262, 282–286. [Google Scholar] [CrossRef]
  8. Hester, G.; Brenner-Holzach, O.; Rossi, F.A.; Struck-Donatz, M.; Piontek, K. The crystal structure of fructose-1,6-bisphosphate aldolase from Drosophila melanogaster at 2.5 A resolution. FEBS Lett. 1991, 292, 237–242. [Google Scholar]
  9. Sygusch, J.; Beaudry, D.; Allaire, M. Molecular architecture of rabbit skeletal muscle aldolase at 2.7-A resolution. Proc. Natl. Acad. Sci. USA 1987, 84, 7846–7850. [Google Scholar] [CrossRef]
  10. Prasad, C.S.; Gupta, S.; Kumar, H.; Tiwari, M. Evolutionary and functional analysis of fructose bisphosphate aldolase of plant parasitic nematodes. Bioinformation 2013, 9, 1–8. [Google Scholar] [CrossRef]
  11. Kochman, M.; Krzywda, U.; Kwiatkowska, D.; Baranowski, T. Multiple molecular forms of fructose diphosphate aldolase in ontogeny and phylogeny. Int. J. Biochem. 1971, 2, 221–231. [Google Scholar] [CrossRef]
  12. Lu, M.; Sautin, Y.Y.; Holliday, L.S.; Gluck, S.L. The Glycolytic Enzyme Aldolase Mediates Assembly, Expression, and Activity of Vacuolar H+-ATPase. J. Biol. Chem. 2004, 279, 8732–8739. [Google Scholar] [CrossRef] [PubMed]
  13. Tochio, T.; Tanaka, H.; Nakata, S.; Hosoya, H. Fructose-1,6-bisphosphate aldolase A is involved in HaCaT cell migration by inducing lamellipodia formation. J. Dermatol. Sci. 2010, 58, 123–129. [Google Scholar] [CrossRef]
  14. Chiquete-Felix, N.; Hernandez, J.M.; Mendez, J.A.; Zepeda-Bastida, A.; Chagolla-Lopez, A.; Mujica, A. In guinea pig sperm, aldolase A forms a complex with actin, WAS, and Arp2/3 that plays a role in actin polymerization. Reproduction 2009, 137, 669–678. [Google Scholar] [CrossRef] [PubMed]
  15. Lorentzen, E.; Pohl, E.; Zwart, P.; Stark, A.; Russell, R.B.; Knura, T.; Hensel, R.; Siebers, B. Crystal structure of an archaeal class I aldolase and the evolution of (betaalpha)8 barrel proteins. J. Biol. Chem. 2003, 278, 47253–47260. [Google Scholar] [CrossRef]
  16. Lorentzen, E.; Siebers, B.; Hensel, R. Structure, function and evolution of the Archaeal class I fructose-1,6-bisphosphate aldolase. Biochem. Soc. Trans. 2004, 32, 259–263. [Google Scholar] [CrossRef]
  17. Bednarski, M.D.; Simon, E.S.; Bischofberger, N.; Fessner, W.D.; Kim, M.J.; Lees, W.; Saito, T.; Waldmann, H.; Whitesides, G.M. Rabbit muscle aldolase as a catalyst in organic synthesis. J. Am. Chem. Soc. 1989, 111, 627–635. [Google Scholar] [CrossRef]
  18. Li, Z.; Cai, L.; Wei, M.; Peng, G.W. One-pot four-enzyme synthesis of ketoses with fructose 1,6-bisphosphate aldolases from Staphylococcus carnosus and rabbit muscle. Carbohydr. Res. 2012, 357, 143–146. [Google Scholar] [CrossRef]
  19. Dawson, N.J.; Neal, J.; Dawson; Kyle, K.; Biggar; Kenneth, B.; Storey. Characterization of Fructose-1,6-Bisphosphate Aldolase during Anoxia in the Tolerant Turtle, Trachemys scripta elegans: An Assessment of Enzyme Activity, Expression and Structure. PLoS ONE 2013, 8, e68830. [Google Scholar] [CrossRef]
  20. Prado, S.; Cerdán, M.E.; Siso, M. Isolation and transcriptional regulation of the Kluyveromyces lactis FBA1 (fructose-1,6-bisphosphate aldolase) gene. Can. J. Microbiol. 2004, 50, 645–652. [Google Scholar] [CrossRef]
  21. Wang, L.; Xue, C.; Wang, Y.; Yang, B. Extraction of Proteins with Low Fluoride Level from Antarctic Krill (Euphausia superba) and Their Composition Analysis. J. Agric. Food Chem. 2011, 59, 6108–6112. [Google Scholar] [CrossRef] [PubMed]
  22. Schaafsma, F.L.; David, C.L.; Kohlbach, D.; Ehrlich, J.; Castellani, G.; Lange, B.A.; Vortkamp, M.; Meijboom, A.; Fortuna-Wünsch, A.; Immerz, A.; et al. Allometric relationships of ecologically important Antarctic and Arctic zooplankton and fish species. Polar Biol. 2022, 45, 203–224. [Google Scholar] [CrossRef] [PubMed]
  23. Liu, M.; Tao, Z.; Zhang, Y.; Yang, G.; Sun, S.; Li, C.; Le, F. Feeding strategies of Euphausia superba in the eastern South Shetland Islands in austral summer. Acta Oceanol. Sin. 2019, 38, 75–83. [Google Scholar] [CrossRef]
  24. Dai, Y.; Zhang, L.; Yan, Z.; Li, Z.; Fu, M.; Xue, C.; Wang, J. A low proportion n-6/n-3 PUFA diet supplemented with Antarctic krill (Euphausia superba) oil protects against osteoarthritis by attenuating inflammation in ovariectomized mice. Food Funct. 2021, 12, 6766–6779. [Google Scholar] [CrossRef] [PubMed]
  25. Hu, S.; Wu, J.; Zhu, B.; Du, M.; Wu, C.; Yu, C.; Song, L.; Xu, X. Low oil emulsion gel stabilized by defatted Antarctic krill (Euphausia superba) protein using high-intensity ultrasound. Ultrason. Sonochem. 2020, 70, 105294. [Google Scholar] [CrossRef]
  26. Han, L.H.; Mao, X.Z.; Wang, K.; Li, Y.Y.; Zhao, M.H. Phosphorylated peptides from Antarctic krill (Euphausia superba) ameliorated osteoporosis by activation of osteogenesis-related MAPKs and PI3K/AKT/GSK-3 beta pathways in dexamethasone-treated mice. J. Funct. Foods 2018, 47, 447–456. [Google Scholar] [CrossRef]
  27. Zhang, S.Y.; Zhao, G.X.; Suo, S.K.; Wang, Y.M.; Chi, C.F.; Wang, B. Purification, Identification, Activity Evaluation, and Stability of Antioxidant Peptides from Alcalase Hydrolysate of Antarctic Krill (Euphausia superba) Proteins. Mar. Drugs 2021, 19, 347. [Google Scholar] [CrossRef]
  28. Ning, Z.; Li, J.; Chunhong, L.; Zhang, R.Y.; Sieber, H.C.; Li, Y.H.; Loers, G.; Petridis, A.K.; Xia, Z.Y.; Dong, H.J.; et al. An antarctic krill oil-based diet elicits neuroprotective effects by inhibiting oxidative stress and rebalancing the M1/M2 microglia phenotype in a cuprizone model for demyelination. J. Funct. Foods 2021, 76, 104309. [Google Scholar]
  29. Berg, I.; Kalfas, S.; Malmsten, M.; Arnebrant, T. Proteolytic degradation of oral biofilms in vitro and in vivo: Potential of proteases originating from Euphausia superba for plaque control. Eur. J. Oral Sci. 2010, 109, 316–324. [Google Scholar] [CrossRef]
  30. Zhou, T.; Wang, X.; Yan, J.; Li, Y. Gene analysis and structure prediction for the cold-adaption mechanism of trypsin from the krill Euphausia superba (Dana, 1852). J. Sci. Food Agric. 2018, 98, 3049–3056. [Google Scholar] [CrossRef]
  31. Ellingsen, T.E.; Mohr, V. Biochemistry of the autolytic processes in Antarctic krill postmortem. Biochem. J. 1987, 246, 295. [Google Scholar] [CrossRef] [PubMed]
  32. Sjödahl, J.; Emmer, A.; Vincent, J.; Roeraade, J. Characterization of proteinases from Antarctic krill (Euphausia superba). Protein Expr. Purif. 2002, 26, 153–161. [Google Scholar] [CrossRef]
  33. Ziveri, J.; Tros, F.; Guerrera, I.C.; Chhuon, C.; Audry, M.; Dupuis, M.; Barel, M.; Korniotis, S.; Fillatreau, S.; Gales, L.; et al. The metabolic enzyme fructose-1,6-bisphosphate aldolase acts as a transcriptional regulator in pathogenic. Nat. Commun. 2017, 8, 853. [Google Scholar] [CrossRef] [PubMed]
  34. Mccarthy, J.S.; Wieseman, M.; Tropea, J.; McCarthy, J.S.; Wieseman, M.; Tropea, J.; Kaslow, D.; Abraham, D.; Lustigman, S.; Tuan, R.; et al. Onchocerca volvulus glycolytic enzyme fructose-1,6-bisphosphate aldolase as a target for a protective immune response in humans. Infect. Immun. 2019, 70, 851–858. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Yan, K.; Wang, B.; Zhou, H.; Luo, Q.L.; Zhong, Z.R. Amelioration of type 1 diabetes by recombinant fructose-1,6-bisphosphate aldolase and cystatin derived from Schistosoma japonicum in a murine model. Parasitol. Res. 2020, 119, 1753–1767. [Google Scholar] [CrossRef] [PubMed]
  36. Bezerra, M.A.; Santelli, R.E.; Oliveira, E.P.; Villar, L.S.; Escaleira, L.A. Response surface methodology (RSM) as a tool for optimization in analytical chemistry. Talanta 2008, 76, 965–977. [Google Scholar] [CrossRef]
  37. Kochman, M.; Kwiatkowska, D. Purification and properties of fructose diphosphate aldolase from Ascaris suum muscle. Arch. Biochem. Biophys. 1972, 152, 856–868. [Google Scholar] [CrossRef]
  38. Götz, F.; Fischer, S.; Schleifer, K.H. Purification and characterisation of an unusually heat-stable and acid/base-stable class I fructose-1,6-bisphosphate aldolase from Staphylococcus aureus. FEBS J. 2010, 108, 295–301. [Google Scholar] [CrossRef]
  39. Willard, M.J.; Gibbs, M. Fructose-diphosphate aldolase from blue-green algae. Methods Enzymol. 1975, 42, 228–231. [Google Scholar]
  40. Dalby, A.; Dauter, Z.; Littlechild, J.A. Crystal structure of human muscle aldolase complexed with fructose 1,6-bisphosphate: Mechanistic implications. Protein Sci. 2010, 8, 291–297. [Google Scholar] [CrossRef]
  41. Lorentzen, E.; Siebers, B.; Hensel, R.; Pohl, E. Mechanism of the Schiff base forming fructose-1,6-bisphosphate aldolase: Structural analysis of reaction intermediates. Biochemistry 2005, 44, 4222. [Google Scholar] [CrossRef] [PubMed]
  42. Rellos, P.; Sygusch, J.; Cox, T.M. Expression, purification, and characterization of natural mutants of human aldolase B. Role of quaternary structure in catalysis. J. Biol. Chem. 2000, 275, 1145. [Google Scholar] [CrossRef] [PubMed]
  43. Pédelacq, J.D.; Cabantous, S.; Tran, T.; Terwilliger, T.C.; Waldo, G.S. Engineering and characterization of a superfolder green fluorescent protein. Nat. Biotechnol. 2006, 24, 79–88. [Google Scholar] [CrossRef]
  44. Zhang, Z.; Tang, R.; Zhu, D.; Wang, W.; Yi, L.; Ma, L. Non-peptide guided auto-secretion of recombinant proteins by super-folder green fluorescent protein in. Sci. Rep. 2017, 7, 6990. [Google Scholar] [CrossRef] [PubMed]
  45. Maurady, A.; Zdanov, A.; Moissac, D.D.; Beaudry, D.; Sygusch, J. A conserved glutamate residue exhibits multifunctional catalytic roles in D-fructose-1,6-bisphosphate aldolases. J. Biol. Chem. 2002, 277, 9474–9483. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Morris, A.J.; Tolan, D.R. Site-directed mutagenesis identifies aspartate 33 as a previously unidentified critical residue in the catalytic mechanism of rabbit aldolase A. J. Biol. Chem. 1993, 268, 1095. [Google Scholar] [CrossRef]
  47. Morris, A.J.; Tolan, D.R. Lysine-146 of rabbit muscle aldolase is essential for cleavage and condensation of the C3-C4 bond of fructose 1,6-bis(phosphate). Biochemistry 1994, 33, 12291–12297. [Google Scholar] [CrossRef]
Ijms 23 10478 g001 550
Figure 1. Chemical catalyzed by fructose-1,6-bisphosphate aldolase (FBA). FBA catalyzes the cleavage of fructose 1,6-diphosphate (FBP) to dihydroxyacetone phosphate (DHAP) and glycerol 3-phosphate (G3P).
Figure 1. Chemical catalyzed by fructose-1,6-bisphosphate aldolase (FBA). FBA catalyzes the cleavage of fructose 1,6-diphosphate (FBP) to dihydroxyacetone phosphate (DHAP) and glycerol 3-phosphate (G3P).
Ijms 23 10478 g001
Ijms 23 10478 g002 550
Figure 2. EsFBA 3D structure prediction diagram. (A) 3D structure prediction map of Euphausia superba FBA; (B) human A-type FBA 3D structure template; (C) 3D structure prediction map of the FBA tetramer in Euphausia superba; (D) template diagram of the human FBA-A 3D structure.
Figure 2. EsFBA 3D structure prediction diagram. (A) 3D structure prediction map of Euphausia superba FBA; (B) human A-type FBA 3D structure template; (C) 3D structure prediction map of the FBA tetramer in Euphausia superba; (D) template diagram of the human FBA-A 3D structure.
Ijms 23 10478 g002
Ijms 23 10478 g003 550
Figure 3. Multiple-sequence alignment of EsFBA and other reported fructose-1,6-bisphosphate aldolases. Conserved amino acids are highlighted in black.
Figure 3. Multiple-sequence alignment of EsFBA and other reported fructose-1,6-bisphosphate aldolases. Conserved amino acids are highlighted in black.
Ijms 23 10478 g003
Ijms 23 10478 g004 550
Figure 4. Sodium dodecyl sulfate–polyacrylamide gel electrophoresis analyses of recombinant EsFBA on a 10% gel. M: marker; Lane 1: protein purified from 500 mM imidazole; Lane 2: protein purified from 500 mM imidazole; Lane 3: supernatant.
Figure 4. Sodium dodecyl sulfate–polyacrylamide gel electrophoresis analyses of recombinant EsFBA on a 10% gel. M: marker; Lane 1: protein purified from 500 mM imidazole; Lane 2: protein purified from 500 mM imidazole; Lane 3: supernatant.
Ijms 23 10478 g004
Ijms 23 10478 g005 550
Figure 5. Characterization of recombinant EsFBA. (a) Optimum temperature, (b) optimum pH, (c) temperature stability, and (d) pH stability.
Figure 5. Characterization of recombinant EsFBA. (a) Optimum temperature, (b) optimum pH, (c) temperature stability, and (d) pH stability.
Ijms 23 10478 g005
Ijms 23 10478 g006 550
Figure 6. EsFBA activity in the presence of metal ions.
Figure 6. EsFBA activity in the presence of metal ions.
Ijms 23 10478 g006
Ijms 23 10478 g007 550
Figure 7. Substrate hydrogen-bonding simulation diagram. Yellow dashed lines represent the hydrogen bonds interacting with the substrate fructose-1,6-bisphosphate (FBP), where Lys147 and Lys230 are hydrogen-bonded to the substrate.
Figure 7. Substrate hydrogen-bonding simulation diagram. Yellow dashed lines represent the hydrogen bonds interacting with the substrate fructose-1,6-bisphosphate (FBP), where Lys147 and Lys230 are hydrogen-bonded to the substrate.
Ijms 23 10478 g007
Ijms 23 10478 g008 550
Figure 8. Diagram showing the interaction between mutated or wild-type amino acids with the substrate. (a) D34K, (b) K147D, (c) E188H, and (d) K230D.
Figure 8. Diagram showing the interaction between mutated or wild-type amino acids with the substrate. (a) D34K, (b) K147D, (c) E188H, and (d) K230D.
Ijms 23 10478 g008
Ijms 23 10478 g009 550
Figure 9. Catalytic processes involving fructose-1,6-bisphosphate aldolase. FBA reversibly catalyzes the cleavage of FBP to DHAP and G3P, where G3P is converted to DHAP via TPIase and DHAP is converted to glycerol 3-phosphate by GPS. NADH is converted to NAD+ in the process.
Figure 9. Catalytic processes involving fructose-1,6-bisphosphate aldolase. FBA reversibly catalyzes the cleavage of FBP to DHAP and G3P, where G3P is converted to DHAP via TPIase and DHAP is converted to glycerol 3-phosphate by GPS. NADH is converted to NAD+ in the process.
Ijms 23 10478 g009
Table
Table 1. Purification of recombinant EsFBA.
Table 1. Purification of recombinant EsFBA.
Total
Activity (U)		Protein
Concentration
(mg/mL)		Specific
Activity (U/mg)		Purification FoldYield (%)
Crude enzyme799.88.19.51100
Ni2+-NTA280.40.7193.520.435.1
Table
Table 2. Enzyme activity of wild type and mutant.
Table 2. Enzyme activity of wild type and mutant.
Enzyme Activity (U/mg)Relative Enzyme Activity
Wild type193.5 ± 0.37100%
D34K191.9 ± 1.0599%
K147D93.2 ± 1.3448%
E188H143.7 ± 0.9874%
K230D101.7 ± 0.7253%
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Xia, J.; Xin, W.; Wang, F.; Xie, W.; Liu, Y.; Xu, J. Cloning and Characterization of Fructose-1,6-Bisphosphate Aldolase from Euphausia superba. Int. J. Mol. Sci. 2022, 23, 10478. https://doi.org/10.3390/ijms231810478

AMA Style

Xia J, Xin W, Wang F, Xie W, Liu Y, Xu J. Cloning and Characterization of Fructose-1,6-Bisphosphate Aldolase from Euphausia superba. International Journal of Molecular Sciences. 2022; 23(18):10478. https://doi.org/10.3390/ijms231810478

Chicago/Turabian Style

Xia, Jikun, Wanmeng Xin, Fang Wang, Wancui Xie, Yi Liu, and Jiakun Xu. 2022. "Cloning and Characterization of Fructose-1,6-Bisphosphate Aldolase from Euphausia superba" International Journal of Molecular Sciences 23, no. 18: 10478. https://doi.org/10.3390/ijms231810478

APA Style

Xia, J., Xin, W., Wang, F., Xie, W., Liu, Y., & Xu, J. (2022). Cloning and Characterization of Fructose-1,6-Bisphosphate Aldolase from Euphausia superba. International Journal of Molecular Sciences, 23(18), 10478. https://doi.org/10.3390/ijms231810478

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop